ArticleClinical rheumatology2007
Cardiac sarcoidosis responding to monotherapy with infliximab.
Article in Clinical rheumatology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 74 citations in OpenAlex.
- Informed consent and biological agents in rheumatology and internal medicine.European journal of clinical investigation · 2022Review
- Controversies in the Treatment of Cardiac Sarcoidosis.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2022Article
- Ten Questions Cardiologists Should Be Able to Answer About Cardiac Sarcoidosis: Case-Based Approach and Contemporary Review.CJC open · 2021Review
- Fulminant cardiac sarcoidosis resembling giant cell myocarditis: a case report.European heart journal. Case reports · 2021Article
- Case Report: TNFα Antagonists Are an Effective Therapy in Cardiac Sarcoidosis.Frontiers in cardiovascular medicine · 2021Article
- TNF-alpha inhibition for the treatment of cardiac sarcoidosis.Seminars in arthritis and rheumatism · 2020Article
- Cardiac sarcoidosis: A long term follow up study.PloS one · 2020Observational
- Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.Journal of the American Heart Association · 2019Article
- Lymph Vessel Proliferation on Cardiac Biopsy May Help in the Diagnosis of Cardiac Sarcoidosis.Journal of the American Heart Association · 2019Article
- Cardiac sarcoidosis mimicking arrhythmogenic right ventricular dysplasia in a patient presenting with monomorphic ventricular tachycardia.HeartRhythm case reports · 2017Article
- A Diagnostic and Therapeutic Approach to Arrhythmias in Cardiac Sarcoidosis.Current treatment options in cardiovascular medicine · 2016Article
- Pathophysiology and clinical management of cardiac sarcoidosis.Nature reviews. Cardiology · 2015Review
- Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.Seminars in respiratory and critical care medicine · 2014Review
- Cardiac sarcoidosis: clinical manifestations, imaging characteristics, and therapeutic approach.Clinical Medicine Insights. Cardiology · 2014Review
- Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis.Mediators of inflammation · 2013Review
- A case series of refractory cutaneous sarcoidosis successfully treated with infliximab.Dermatology and therapy · 2012Article
- Cardiac sarcoidosis: diagnosis and management.Current treatment options in cardiovascular medicine · 2012Article
- The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon.Rheumatology international · 2009Article
- Article
- Ventricular tachycardia as the first manifestation of cardiac sarcoidosis.BMJ case reports · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac involvement is a rare and potentially life-threatening complication of sarcoidosis. We report the case of a young previously healthy woman who presented with complete atrioventricular heart block. Further evaluation revealed non-caseating granulomas in the hilar and mediastinal regions. A pacemaker was inserted, and she was treated with four doses of infliximab after she refused treatment with steroids. Rapid resolution of the pulmonary lymph nodes was documented and repeated interrogations of the pacemaker 1 year after her last infliximab infusion documented that she was in sinus rhythm. Infliximab may be considered as an alternative first-line therapy in sarcoidosis with serious organ involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.